Real-world safety and mortality outcomes of CAR-T cell therapies versus bispecific antibodies in DLBCL: Insights from the faers database [PDF]
Fatma Temiz +2 more
openalex +1 more source
Targeted dual selection to optimize transposon stable pool generation of multispecifics. [PDF]
Johnston J +9 more
europepmc +1 more source
Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema. [PDF]
Wang Z +11 more
europepmc +1 more source
A novel bispecific affitoxin simultaneously targeting E7 of HPV16/18 types: superior anti-tumor activity and EMT reversal in HPV-driven cervical cancer therapy. [PDF]
Wan K +8 more
europepmc +1 more source
The Precision Revolution in Hematologic Malignancies: A Decade of Transformative Immunotherapies and Targeted Agents. [PDF]
Mansour GK, Hajjar AW, Sajid MR.
europepmc +1 more source
Sequencing Cellular Therapies in the Management of Follicular Lymphoma. [PDF]
Jóna Á, Illés Á.
europepmc +1 more source
General strategies for
Yifeng Li
openalex +1 more source
IgE based therapeutics are an emerging modality in cancer treatment. [PDF]
Kumari S, Ghosh S, Doerner A.
europepmc +1 more source

